News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,404 Results
Type
Article (47139)
Company Profile (279)
Press Release (677986)
Multimedia
Podcasts (55)
Webinars (12)
Section
Business (209751)
Career Advice (2134)
Deals (36076)
Drug Delivery (106)
Drug Development (82909)
Employer Resources (174)
FDA (16628)
Job Trends (15328)
News (354187)
Policy (33480)
Tag
Academia (2787)
Accelerated approval (5)
Adcomms (22)
Allergies (87)
Alliances (51378)
ALS (90)
Alzheimer's disease (1434)
Antibody-drug conjugate (ADC) (129)
Approvals (16624)
Artificial intelligence (268)
Autoimmune disease (22)
Automation (16)
Bankruptcy (368)
Best Places to Work (11918)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (192)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (282)
Cancer (2300)
Cardiovascular disease (181)
Career advice (1774)
Career pathing (30)
CAR-T (157)
Cell therapy (435)
Cervical cancer (20)
Clinical research (67298)
Collaboration (849)
Compensation (530)
Complete response letters (20)
COVID-19 (2687)
CRISPR (43)
C-suite (247)
Cystic fibrosis (104)
Data (2222)
Decentralized trials (2)
Denatured (20)
Depression (45)
Diabetes (272)
Diagnostics (6807)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (122)
Drug pricing (108)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (87667)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (115891)
Executive appointments (738)
FDA (17908)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (763)
Gene editing (109)
Generative AI (24)
Gene therapy (316)
GLP-1 (727)
Government (4595)
Grass and pollen (4)
Guidances (65)
Healthcare (19656)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2841)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (338)
IPO (16729)
IRA (44)
Job creations (3823)
Job search strategy (1512)
Kidney cancer (10)
Labor market (38)
Layoffs (480)
Leadership (17)
Legal (8104)
Liver cancer (80)
Lung cancer (327)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (316)
MASH (68)
Medical device (13754)
Medtech (13759)
Mergers & acquisitions (19887)
Metabolic disorders (694)
Multiple sclerosis (81)
NASH (17)
Neurodegenerative disease (92)
Neuropsychiatric disorders (28)
Neuroscience (1978)
NextGen: Class of 2025 (6861)
Non-profit (4725)
Now hiring (39)
Obesity (367)
Opinion (209)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (83)
Parkinson's disease (151)
Partnered (21)
Patents (239)
Patient recruitment (114)
Peanut (48)
People (58972)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20991)
Phase II (29601)
Phase III (22025)
Pipeline (1209)
Policy (145)
Postmarket research (2680)
Preclinical (9020)
Press Release (71)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (255)
Rare diseases (393)
Real estate (6375)
Recruiting (65)
Regulatory (22913)
Reports (46)
Research institute (2493)
Resumes & cover letters (369)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (71)
Series A (133)
Series B (85)
Service/supplier (13)
Sickle cell disease (56)
Special edition (14)
Spinal muscular atrophy (150)
Sponsored (31)
Startups (3757)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (41)
The Weekly (33)
Vaccines (725)
Venture capitalists (42)
Weight loss (239)
Women's health (35)
Worklife (16)
Date
Today (204)
Last 7 days (907)
Last 30 days (2700)
Last 365 days (33490)
2025 (10896)
2024 (35908)
2023 (40859)
2022 (52084)
2021 (56661)
2020 (55343)
2019 (48137)
2018 (36346)
2017 (33142)
2016 (32797)
2015 (38919)
2014 (32640)
2013 (27950)
2012 (30193)
2011 (30749)
2010 (28918)
Location
Africa (761)
Alabama (53)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (39785)
Australia (6474)
California (6203)
Canada (2022)
China (532)
Colorado (269)
Connecticut (277)
Delaware (150)
Europe (86349)
Florida (918)
Georgia (214)
Idaho (60)
Illinois (555)
India (25)
Indiana (311)
Iowa (11)
Japan (164)
Kansas (106)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (915)
Massachusetts (4622)
Michigan (221)
Minnesota (400)
Mississippi (2)
Missouri (84)
Montana (31)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1746)
New Mexico (30)
New York (1769)
North Carolina (1020)
North Dakota (9)
Northern California (2696)
Ohio (209)
Oklahoma (14)
Oregon (35)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (33)
South America (1158)
South Carolina (23)
South Dakota (1)
Southern California (2340)
Tennessee (104)
Texas (921)
United States (23493)
Utah (185)
Virginia (148)
Washington D.C. (63)
Washington State (567)
West Virginia (3)
Wisconsin (62)
725,404 Results for "dna diagnostics center inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
DNA Diagnostics Center Partners with Contraline in ADAMTM Clinical Trial, Testing Revolutionary Male Contraceptive
DNA Diagnostics Center Partners with Contraline in ADAM TM Clinical Trial, Testing Revolutionary Male Contraceptive.
June 21, 2024
·
3 min read
Press Releases
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics’ EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
April 25, 2025
·
4 min read
Press Releases
Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test
March 13, 2025
·
3 min read
Press Releases
The global DNA diagnostics market size was US$ 11.18 billion in 2024
February 26, 2025
·
1 min read
Press Releases
The Center for Immunology Science and Immunology Diagnostics Announce a Major Breakthrough Discovery: DNA-Based Proof of the Disease of Fibromyalgia
September 9, 2024
·
2 min read
Pharm Country
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program
Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc., announced that it was notified by the World Trade Center Health Program that, due to a clerical error, the EsoGuard® Esophageal DNA test was incorrectly listed as a covered benefit.
February 16, 2024
·
3 min read
Press Releases
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
April 25, 2025
·
8 min read
Press Releases
Applied DNA’s LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
April 22, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
April 29, 2025
·
1 min read
Press Releases
CellFE® Partners with DKFZ and TcellTech to Advance DNA Vector Genetic Engineering for Cellular Therapies
April 30, 2025
·
4 min read
1 of 72,541
Next
